169 related articles for article (PubMed ID: 27178839)
1. Structure/Function Relations in AIFM1 Variants Associated with Neurodegenerative Disorders.
Sevrioukova IF
J Mol Biol; 2016 Sep; 428(18):3650-65. PubMed ID: 27178839
[TBL] [Abstract][Full Text] [Related]
2. From ventriculomegaly to severe muscular atrophy: expansion of the clinical spectrum related to mutations in AIFM1.
Kettwig M; Schubach M; Zimmermann FA; Klinge L; Mayr JA; Biskup S; Sperl W; Gärtner J; Huppke P
Mitochondrion; 2015 Mar; 21():12-8. PubMed ID: 25583628
[TBL] [Abstract][Full Text] [Related]
3. Key Role of the Adenylate Moiety and Integrity of the Adenylate-Binding Site for the NAD(+)/H Binding to Mitochondrial Apoptosis-Inducing Factor.
Sorrentino L; Calogero AM; Pandini V; Vanoni MA; Sevrioukova IF; Aliverti A
Biochemistry; 2015 Dec; 54(47):6996-7009. PubMed ID: 26535916
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-inducing factor: structure, function, and redox regulation.
Sevrioukova IF
Antioxid Redox Signal; 2011 Jun; 14(12):2545-79. PubMed ID: 20868295
[TBL] [Abstract][Full Text] [Related]
5. Cowchock syndrome is associated with a mutation in apoptosis-inducing factor.
Rinaldi C; Grunseich C; Sevrioukova IF; Schindler A; Horkayne-Szakaly I; Lamperti C; Landouré G; Kennerson ML; Burnett BG; Bönnemann C; Biesecker LG; Ghezzi D; Zeviani M; Fischbeck KH
Am J Hum Genet; 2012 Dec; 91(6):1095-102. PubMed ID: 23217327
[TBL] [Abstract][Full Text] [Related]
6. Structural bases of the altered catalytic properties of a pathogenic variant of apoptosis inducing factor.
Sorrentino L; Cossu F; Milani M; Aliverti A; Mastrangelo E
Biochem Biophys Res Commun; 2017 Aug; 490(3):1011-1017. PubMed ID: 28666871
[TBL] [Abstract][Full Text] [Related]
7. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor.
Ghezzi D; Sevrioukova I; Invernizzi F; Lamperti C; Mora M; D'Adamo P; Novara F; Zuffardi O; Uziel G; Zeviani M
Am J Hum Genet; 2010 Apr; 86(4):639-49. PubMed ID: 20362274
[TBL] [Abstract][Full Text] [Related]
8.
Qiu Y; Wang H; Pan H; Guan J; Yan L; Fan M; Zhou H; Zhou X; Wu K; Jia Z; Zhuang Q; Lei Z; Li M; Ding X; Lin A; Fu Y; Zhang D; Wang Q; Yan Q
J Zhejiang Univ Sci B; 2023 Feb; 24(2):172-184. PubMed ID: 36751702
[TBL] [Abstract][Full Text] [Related]
9. The oxido-reductase activity of the apoptosis inducing factor: a promising pharmacological tool?
Ferreira P; Villanueva R; Cabon L; Susín SA; Medina M
Curr Pharm Des; 2013; 19(14):2628-36. PubMed ID: 23116400
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH:Ubiquinone Oxidoreductases (NDH-2).
Elguindy MM; Nakamaru-Ogiso E
J Biol Chem; 2015 Aug; 290(34):20815-20826. PubMed ID: 26063804
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer.
Bano D; Prehn JHM
EBioMedicine; 2018 Apr; 30():29-37. PubMed ID: 29605508
[TBL] [Abstract][Full Text] [Related]
12. Redox- and Ligand Binding-Dependent Conformational Ensembles in the Human Apoptosis-Inducing Factor Regulate Its Pro-Life and Cell Death Functions.
Villanueva R; Romero-Tamayo S; Laplaza R; Martínez-Olivan J; Velázquez-Campoy A; Sancho J; Ferreira P; Medina M
Antioxid Redox Signal; 2019 Jun; 30(18):2013-2029. PubMed ID: 30450916
[No Abstract] [Full Text] [Related]
13. Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked
Moss T; May M; Flanagan-Steet H; Caylor R; Jiang YH; McDonald M; Friez M; McConkie-Rosell A; Steet R
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117073
[TBL] [Abstract][Full Text] [Related]
14. Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradation.
Lewis EM; Wilkinson AS; Davis NY; Horita DA; Wilkinson JC
Biochemistry; 2011 Dec; 50(51):11084-96. PubMed ID: 22103349
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-inducing factor: a matter of neuron life and death.
Krantic S; Mechawar N; Reix S; Quirion R
Prog Neurobiol; 2007 Feb; 81(3):179-96. PubMed ID: 17267093
[TBL] [Abstract][Full Text] [Related]
16. A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease.
Diodato D; Tasca G; Verrigni D; D'Amico A; Rizza T; Tozzi G; Martinelli D; Verardo M; Invernizzi F; Nasca A; Bellacchio E; Ghezzi D; Piemonte F; Dionisi-Vici C; Carrozzo R; Bertini E
Eur J Hum Genet; 2016 Mar; 24(3):463-6. PubMed ID: 26173962
[TBL] [Abstract][Full Text] [Related]
17. AIF translocation into nucleus caused by Aifm1 R450Q mutation: generation and characterization of a mouse model for AUNX1.
Shi T; Chen Z; Li J; Wang H; Wang Q
Hum Mol Genet; 2024 May; 33(10):905-918. PubMed ID: 38449065
[TBL] [Abstract][Full Text] [Related]
18. Redox-linked conformational dynamics in apoptosis-inducing factor.
Sevrioukova IF
J Mol Biol; 2009 Jul; 390(5):924-38. PubMed ID: 19447115
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of apoptosis-inducing factor (AIF) to disulfide-linked conjugates.
Lo SM; Martinez PA; Marques EF; Miyamoto S; Valdameri G; Moure VR; Zanata SM; Nakao LS
Arch Biochem Biophys; 2020 Oct; 692():108515. PubMed ID: 32791141
[TBL] [Abstract][Full Text] [Related]
20. Redox reactions of the FAD-containing apoptosis-inducing factor (AIF) with quinoidal xenobiotics: a mechanistic study.
Misevičienė L; Anusevičius Z; Sarlauskas J; Sevrioukova IF; Cėnas N
Arch Biochem Biophys; 2011 Aug; 512(2):183-9. PubMed ID: 21664341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
